(VIANEWS) – TIETOEVRY (TIETO.OL), UCB (UCB.BR), SODEXO (SW.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio so far. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. TIETOEVRY (TIETO.OL)
100% Payout Ratio
TietoEVRY Oyj operates as a software and services company. It operates through five segments: Tietoevry Create, Tietoevry Banking, Tietoevry Care, Tietoevry Industry, and Tietoevry Tech Services. The Tietoevry Create segment provides digital agenda to create competitive products, as well as uses design, data, and cloud technologies for data-driven businesses. This segment also offers software and data engineering services. The Tietoevry Banking segment provides Banking-as-a-Service platform and software products for digital transformation and financial institutions. The Tietoevry Care segment offers modular and interoperable software, reinventing Nordic health, and social care services. The Tietoevry Industry segment offers software and data solutions to various industries, such as public sector, pulp and paper, and utilities. The Tietoevry Tech Services provides enterprise-wide transformation to customers' business processes, applications and infrastructure; and deep customer knowledge, global cloud & data competencies, automated operations, and multi-cloud platform services. The company was formerly known as Tieto Oyj and changed its name to TietoEVRY Oyj in December 2019. TietoEVRY Oyj was incorporated in 1968 and is headquartered in Espoo, Finland.
Earnings Per Share
As for profitability, TIETOEVRY has a trailing twelve months EPS of kr16.77.
PE Ratio
TIETOEVRY has a trailing twelve months price to earnings ratio of 13.38. Meaning, the purchaser of the share is investing kr13.38 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.34%.
Volume
Today’s last reported volume for TIETOEVRY is 618 which is 64.31% below its average volume of 1732.
Moving Average
TIETOEVRY’s value is below its 50-day moving average of kr243.65 and way under its 200-day moving average of kr250.11.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.1%, now sitting on 2.85B for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 20, 2024, the estimated forward annual dividend rate is 16.7 and the estimated forward annual dividend yield is 7.46%.
More news about TIETOEVRY.
2. UCB (UCB.BR)
75.57% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; minzasolmin and UCB0222 for Parkinson's disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €1.75.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 64.54. Meaning, the purchaser of the share is investing €64.54 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.8%.
Volume
Today’s last reported volume for UCB is 123384 which is 59.37% below its average volume of 303680.
More news about UCB.
3. SODEXO (SW.PA)
63.16% Payout Ratio
Sodexo S.A. provides food services and facilities management services worldwide. It offers various on-site services, which includes corporate services, energy and resources, government and agencies, and other services; healthcare and seniors; and learning solutions to schools and universities. The company also provides food services comprising retail service, food delivery, and meal and food vouchers, as well as digital food ordering services; savings and purchase solutions, data and digital tools, and advisory services and client support; and work-life balance and employee experience solutions. In addition, it offers facility management services, including technical service management, assets management, building maintenance, access control, deep cleaning, energy management, space planning, project management, front-of-house services, grounds maintenance, waste management, HVAC systems, mail management, commercial cleaning, workspace management, and pest control. services. The company was formerly known as Sodexho Alliance and changed its name to Sodexo S.A. in 2008. Sodexo S.A. was founded in 1966 and is headquartered in Issy-les-Moulineaux, France.
Earnings Per Share
As for profitability, SODEXO has a trailing twelve months EPS of €3.8.
PE Ratio
SODEXO has a trailing twelve months price to earnings ratio of 20.6. Meaning, the purchaser of the share is investing €20.6 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.65%.
Yearly Top and Bottom Value
SODEXO’s stock is valued at €78.28 at 21:10 EST, below its 52-week high of €79.44 and way above its 52-week low of €62.86.
More news about SODEXO.
4. ADP (ADP.PA)
54.53% Payout Ratio
Aeroports de Paris SA owns and operates airports worldwide. The company operates through Aviation, Retail and Services, Real Estate, International and Airport Developments, and Other Activities segments. The Aviation segment provides security and airport safety services, including security checkpoints, screening systems, aircraft rescue, and fire-fighting services. The Retail and Services segment engages in the retail activities, including bars, restaurants, banks, car rentals, and retails shops, as well as leases space for terminals, advertising, restaurant, and car park services. This segment also engages in the production and supply of heat, drinking water, and access to the chilled distribution networks. The Real Estate segment engages in the construction, commercialization, and lease management of office buildings, logistic buildings, and freight terminals; and provides property leasing services for airport terminals, as well as rents serviced land. The International and Airport Developments segment designs and operates airport activities. The Other Activities segment offers telecom and cybersecurity services. Aeroports de Paris SA was incorporated in 1945 and is based in Tremblay-en-France, France.
Earnings Per Share
As for profitability, ADP has a trailing twelve months EPS of €6.39.
PE Ratio
ADP has a trailing twelve months price to earnings ratio of 19.87. Meaning, the purchaser of the share is investing €19.87 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.28%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 5, 2023, the estimated forward annual dividend rate is 3.13 and the estimated forward annual dividend yield is 2.66%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 26.9%, now sitting on 5.23B for the twelve trailing months.
Moving Average
ADP’s value is way above its 50-day moving average of €114.91 and above its 200-day moving average of €123.36.
More news about ADP.
5. SCATEC (SCATC.OL)
49.11% Payout Ratio
Scatec ASA, together with its subsidiaries, provides renewable energy solutions worldwide. The company operates through Power Production; Services; and Development & Construction segments. It produces and sells solar, winds, and hydro generated electricity. The company also develops, builds, owns, and operates solar, wind, and hydro power plants and storage solutions. The company is also involved in the engineering, procurement, and construction, as well as operation, maintenance, and asset management of power plants. It has a total of 4.2 GW in operation and under construction. The company was formerly known as Scatec Solar ASA and changed its name to Scatec ASA in November 2020. Scatec ASA was incorporated in 2007 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, SCATEC has a trailing twelve months EPS of kr3.95.
PE Ratio
SCATEC has a trailing twelve months price to earnings ratio of 18.58. Meaning, the purchaser of the share is investing kr18.58 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.58%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.2%, now sitting on 3.4B for the twelve trailing months.
More news about SCATEC.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 1’s stock is considered to be overbought (>=80).
More news about 1.
